aRCC: 1L Treatment Options and Patient Management

T

Overview of CheckMate 214: 5-Year Data on Nivo+Ipi in Patients With Advanced RCC

By Thomas Hutson 2 Videos
99 views
November 30, 2021
Comments 0
Login to view comments. Click here to Login
12:14

ASCO GU 2022 Update on CheckMate 214 With Extended 5-Year Follow-Up:…

ASCO Genitourinary Cancers Symposium

S. Tykodi

186 views
16:00

ASCO GU 2022 Germline Mutations of Interests in Renal Cell Carcinoma

ASCO Genitourinary Cancers Symposium

M. Dean

192 views
09:23

ASCO GU 2022 on Molecular Alterations Across Sites of Metastasis in …

ASCO Genitourinary Cancers Symposium

R. McKay

78 views
16:34

ASCO GU 2022 Highlights on Adjuvant and Consolidative Therapy in Oli…

ASCO Genitourinary Cancers Symposium

N. Haas

147 views
06:04

ASCO 2022 on Safety & Clinical Activity of MEDI5752, a PD-1/CTLA-4 B…

ASCO 2022 Conference Coverage

L. Albiges

139 views
47:32

Mechanisms of Resistance and Toxicity to Immune Checkpoint Therapy i…

Moffitt Cancer Center

J. Gao

249 views
13:28

2022 ASCO Renal Cell Carcinoma Updates

Total Health

M. Bupathi

199 views
12:53

Dual Immunotherapy in RCC

O'Neal Comprehensive Cancer Center at UAB

A. Basu

550 views
20:47

ESMO 2022 on the Latest in mRCC

ecancer

J. Puente, B. Escudier, V. Grünwald, S. Oudard

196 views
21:09

Evolving Landscape of 1L Systemic Treatment in Metastatic Renal Cell…

Mário Fontes-Sousa

232 views
20:23

Choosing Wisely: 1L Combination Treatment for Advanced RCC

Aly-Khan A. Lalani

749 views
06:50

ESMO 2022 Updates in Renal Cancer

ecancer

T. Choueiri

298 views
19:41

How I Manage Immune Adverse Events in Solid Tumors

Balazs Halmos

1.9K views
10:55

Systemic Therapies for Clear Cell RCC: Where Are We Now?

Yale Cancer Center

D. Braun

468 views
14:14

GU Tumor Board: 61 y/o Male With mRCC With Disease Progression After…

PrecisCa

M. Rettig, S. Slovin, T. Fraum, J. Abel, P. Patel

206 views